Drawing for SCAFFOLD

USPTO serial 97604519

SCAFFOLD

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SOBRAL,CHRISTINA
Law office
TMEG LAW OFFICE 109

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SCAFFOLD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

Arlene D. Hanks MOORE & VAN ALLEN PLLC100 NORTH TRYON STREETSUITE 4700CHARLOTTE, NC 28202-4003

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents in the form of lipid nanoparticles that facilitate the delivery of active pharmaceutical ingredients; pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases or respiratory diseasesACTIVE—
042Development of pharmaceutical preparations and medicinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 6, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 6, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 9, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 9, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 9, 2025CNSISUSPENSION INQUIRY WRITTEN—
Aug 22, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 21, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 21, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Feb 21, 2025CNSLSUSPENSION LETTER WRITTEN—
Feb 20, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 30, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 30, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 30, 2025CNSISUSPENSION INQUIRY WRITTEN—
Jul 22, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 22, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jul 22, 2024CNSLSUSPENSION LETTER WRITTEN—
Jul 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 9, 2024ALIEASSIGNED TO LIE—
Jan 17, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 4, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 4, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 4, 2024CNSISUSPENSION INQUIRY WRITTEN—
Jul 7, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 7, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jul 7, 2023CNSLSUSPENSION LETTER WRITTEN—
Jul 7, 2023DOCKASSIGNED TO EXAMINER—
Sep 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance